- Home
- STRO vs TALK Comparison
STRO vs TALK Comparison
Compare STRO & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- TALK
- Stock Information
- Founded
- STRO 2003
- TALK 2012
- Country
- STRO United States
- TALK United States
- Employees
- STRO N/A
- TALK N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- TALK Medical/Nursing Services
- Sector
- STRO Health Care
- TALK Health Care
- Exchange
- STRO Nasdaq
- TALK Nasdaq
- Market Cap
- STRO 172.8M
- TALK 534.6M
- IPO Year
- STRO 2018
- TALK N/A
- Fundamental
- Price
- STRO $1.72
- TALK $2.83
- Analyst Decision
- STRO Strong Buy
- TALK Buy
- Analyst Count
- STRO 7
- TALK 5
- Target Price
- STRO $12.14
- TALK $4.38
- AVG Volume (30 Days)
- STRO 1.1M
- TALK 1.2M
- Earning Date
- STRO 11-13-2024
- TALK 02-20-2025
- Dividend Yield
- STRO N/A
- TALK N/A
- EPS Growth
- STRO N/A
- TALK N/A
- EPS
- STRO N/A
- TALK N/A
- Revenue
- STRO $160,955,000.00
- TALK $181,291,000.00
- Revenue This Year
- STRO N/A
- TALK $28.22
- Revenue Next Year
- STRO N/A
- TALK $23.48
- P/E Ratio
- STRO N/A
- TALK N/A
- Revenue Growth
- STRO 230.90
- TALK 31.50
- 52 Week Low
- STRO $1.67
- TALK $1.60
- 52 Week High
- STRO $6.13
- TALK $3.92
- Technical
- Relative Strength Index (RSI)
- STRO 29.77
- TALK 35.41
- Support Level
- STRO $1.80
- TALK $3.04
- Resistance Level
- STRO $2.15
- TALK $3.33
- Average True Range (ATR)
- STRO 0.13
- TALK 0.15
- MACD
- STRO 0.03
- TALK -0.03
- Stochastic Oscillator
- STRO 10.42
- TALK 10.71
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.